ClinicalTrials.govpublic full text
A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
chronic lymphocytic leukemia, chronic lymphocytic leukemia (cll), navitoclax, abt-263, cancer, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 807515
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.